O'Shaughnessy Asset Management’s NeoGenomics NEO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,264	Closed	-$248K	–	1335
2021 Q4	$248K	Sell	7,264 -24	-0.3%	-$940	﹤0.01%	963
2021 Q3	$352K	Buy	7,288 +1,657	+29%	+$76.7K	0.01%	780
2021 Q2	$254K	Buy	5,631 +18	+0.3%	+$798	0.01%	912
2021 Q1	$270K	Buy	5,613 +6	+0.1%	+$312	0.01%	808
2020 Q4	$302K	Buy	+5,607	New	+$253K	0.01%	688
2019 Q4	–	Sell	-66,467	Closed	-$1.27M	–	1874
2019 Q3	$1.27M	Buy	66,467 +9,278	+16%	+$218K	0.03%	234
2019 Q2	$1.25M	Buy	57,189 +5,241	+10%	+$115K	0.03%	235
2019 Q1	$1.06M	Buy	51,948 +16,799	+48%	+$292K	0.03%	258
2018 Q4	$444K	Buy	35,149 +20,007	+132%	+$298K	0.01%	354
2018 Q3	$230K	Hold	15,142	–	–	﹤0.01%	527
2018 Q2	$197K	Buy	+15,142	New	+$167K	﹤0.01%	546

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

O'Shaughnessy Asset Management's NEO Position: Q1 2022 in Review

O'Shaughnessy Asset Management sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 7,264 shares — an estimated $248K sold.

O'Shaughnessy Asset Management first reported a position in NEO in Q2 2018 and held it in 11 quarters. The position peaked at $1.27M in Q3 2019. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

O'Shaughnessy Asset Management reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
O'Shaughnessy Asset Management sold 7,264 NeoGenomics shares in Q1 2022, an estimated $248K.
O'Shaughnessy Asset Management first reported a position in NeoGenomics in Q2 2018 and held it in 11 quarters.
O'Shaughnessy Asset Management's NeoGenomics position peaked at $1.27M in Q3 2019.
279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2022, filed 13 May 2022.